Exact Mass: 191.04298540000002

Exact Mass Matches: 191.04298540000002

Found 23 metabolites which its exact mass value is equals to given mass value 191.04298540000002, within given mass tolerance error 4.0E-5 dalton. Try search metabolite list with more accurate mass tolerance error 8.0E-6 dalton.

Nitrilotriacetic acid

alpha,Alpha,alpha-trimethylaminetricarboxylic acid

C6H9NO6 (191.04298540000002)


D064449 - Sequestering Agents > D002614 - Chelating Agents

   

Isosorbide Mononitrate

(3R,3aS,6S,6aR)-6-hydroxy-hexahydrofuro[3,2-b]furan-3-yl nitrate

C6H9NO6 (191.04298540000002)


Isosorbide mononitrate (ISMN), sold under the names Imdur and Monoket, among others, is an organic nitrate used principally in the prophylactic treatment of angina pectoris (ischemic chest pain). ISMN is an active metabolite of isosorbide dinitrate and exerts qualitatively similar effects. Like other organic nitrates, ISMN acts as a prodrug for its active metabolite, nitric oxide, which mediates the therapeutic action of ISMN. Nitric oxide works on both arteries and veins, but predominantly veins. Nitric oxide functions by relaxing veins and reducing the central venous pressure, thereby causing venous pooling and a decrease in the venous return to the heart, thus decreasing cardiac preload (PMID: 31643263). The net effect when administering ISMN is therefore a reduced workload for the heart and an improvement in the oxygen supply/demand balance of the myocardium. ISMN is not subject to first pass metabolism in the human liver. Detectable metabolites include isosorbide, sorbitol, and 2-glucuronide of mononitrate, which are pharmacologically inactive (PMID: 1449102). Research on ISMN as a cervical ripener to reduce time at hospital to birth is supportive (PMID: 23983763). Isosorbide mononitrate is only found in individuals who have consumed or used this drug. C - Cardiovascular system > C01 - Cardiac therapy > C01D - Vasodilators used in cardiac diseases > C01DA - Organic nitrates C78274 - Agent Affecting Cardiovascular System > C29707 - Vasodilating Agent D002317 - Cardiovascular Agents > D020030 - Nitric Oxide Donors D002317 - Cardiovascular Agents > D014665 - Vasodilator Agents

   

o-Oxalylhomoserine

2-Amino-4-(2-hydroxy-1,2-dioxoethoxy)butanoic acid

C6H9NO6 (191.04298540000002)


   

gamma-Carboxyglutamic acid

1-aminopropane-1,3,3-tricarboxylic acid

C6H9NO6 (191.04298540000002)


Carboxyglutamic acid (or the conjugate base, carboxyglutamate), is an uncommon amino acid introduced into proteins by a post-translational carboxylation of glutamic acid residues. This modification is found, for example, in clotting factors and other proteins of the coagulation cascade. This modification introduces an affinity for calcium ions. In the blood coagulation cascade, Vitamin K is required to introduce gamma-carboxylation of clotting factors II, VII, IX, X and protein Z.

   

(2s,3r,4s,5r)-3,4,5-Trihydroxy-6-oxopiperidine-2-carboxylic acid

(2s,3r,4s,5r)-3,4,5-Trihydroxy-6-oxopiperidine-2-carboxylic acid

C6H9NO6 (191.04298540000002)


   

Isosorbide 2-nitrate

6-hydroxy-hexahydrofuro[3,2-b]furan-3-yl nitrate

C6H9NO6 (191.04298540000002)


   

O-Oxalylhomoserine

2-amino-4-[(carboxycarbonyl)oxy]butanoic acid

C6H9NO6 (191.04298540000002)


O-oxalylhomoserine is a member of the class of compounds known as alpha amino acids. Alpha amino acids are amino acids in which the amino group is attached to the carbon atom immediately adjacent to the carboxylate group (alpha carbon). O-oxalylhomoserine is slightly soluble (in water) and a moderately acidic compound (based on its pKa). O-oxalylhomoserine can be found in grass pea, which makes O-oxalylhomoserine a potential biomarker for the consumption of this food product.

   

1-Aminopropane-1,2,3-tricarboxylic acid

1-Aminopropane-1,2,3-tricarboxylic acid

C6H9NO6 (191.04298540000002)


   
   
   

H-DL-GLA-OH

1-aminopropane-1,3,3-tricarboxylic acid

C6H9NO6 (191.04298540000002)


   

deuterio 2-[bis(1,1-dideuterio-2-deuteriooxy-2-oxoethyl)amino]-2,2-dideuterioacetate

deuterio 2-[bis(1,1-dideuterio-2-deuteriooxy-2-oxoethyl)amino]-2,2-dideuterioacetate

C6H9NO6 (191.04298540000002)


   

2-(carboxymethylamino)butanedioic acid

2-(carboxymethylamino)butanedioic acid

C6H9NO6 (191.04298540000002)


   
   
   
   

Aspartic Acid-4-Carboxymethyl Ester

Aspartic Acid-4-Carboxymethyl Ester

C6H9NO6 (191.04298540000002)


   

(2S)-2-ammonio-4,4-dicarboxybutanoate

(2S)-2-ammonio-4,4-dicarboxybutanoate

C6H9NO6 (191.04298540000002)


   

Isosorbide Mononitrate

Isosorbide 5-mononitrate

C6H9NO6 (191.04298540000002)


C - Cardiovascular system > C01 - Cardiac therapy > C01D - Vasodilators used in cardiac diseases > C01DA - Organic nitrates C78274 - Agent Affecting Cardiovascular System > C29707 - Vasodilating Agent D002317 - Cardiovascular Agents > D020030 - Nitric Oxide Donors D002317 - Cardiovascular Agents > D014665 - Vasodilator Agents

   

NITRILOTRIACETIC ACID

NITRILOTRIACETIC ACID

C6H9NO6 (191.04298540000002)


D064449 - Sequestering Agents > D002614 - Chelating Agents

   

gamma-carboxy-L-glutamic acid

gamma-carboxy-L-glutamic acid

C6H9NO6 (191.04298540000002)


A non-proteinogenic L-alpha-amino acid that is L-glutamic acid in which one of the gamma-hydrogens is substituted by a carboxy group.

   

gamma-carboxy-L-glutamic acid zwitterion

gamma-carboxy-L-glutamic acid zwitterion

C6H9NO6 (191.04298540000002)


An amino acid zwitterion obtained from gamma-carboxy-L-glutamic acid by transfer of a proton from the alpha-carboxy group to the amino group.